Rights and permissions
About this article
Cite this article
Abciximab reserved for high-risk patients in Asia. Inpharma Wkly. 1509, 4 (2005). https://doi.org/10.2165/00128413-200515090-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200515090-00005